leisure time -WSS

leisure time

author：hotspot 2025-09-06 03:52:54 - browse：17436

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Diversify hospital leadership teams to protect BIPOC patient health

hotspot

WSS

What is the Turing Test that determines if computers can think?

EMA weighs against approval for Mirati's lung cancer drug

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Will General Catalyst be the first of many hospital takeovers?

A clever new way to fix Medicaid and graduate medical education

It's time to take a new tack for treating Alzheimer's

Wikipedia

leisure time

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

More doctors should go into startup world

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Diversify hospital leadership teams to protect BIPOC patient health

Jerome Adams on the need for new antivirals for Covid

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Medical leaders decry Supreme Court decision on affirmative action

Senate panel clears PBM, hopsital reforms

Duchenne breakthrough therapy leaves behind pioneering families

What is artificial intelligence? Experts weigh in

entertainment

STAT Executive Editor Rick Berke on STAT's 8th birthday

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

A clever new way to fix Medicaid and graduate medical education

Victims of gun violence feel impacts long after bullet wound

leisure time

hotspot

knowledge

leisure time